Ocular Therapeutix Inc OCUL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/26/24 EDT
4.80UNCH (UNCH)
Volume
3,726,679
52 week range
2.00 - 11.31
Loading...
  • Open4.73
  • Day High5.19
  • Day Low4.71
  • Prev Close4.80
  • 52 Week High11.31
  • 52 Week High Date03/06/24
  • 52 Week Low2.00
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap713.411M
  • Shares Out148.63M
  • 10 Day Average Volume3.76M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change7.62

KEY STATS

  • Open4.73
  • Day High5.19
  • Day Low4.71
  • Prev Close4.80
  • 52 Week High11.31
  • 52 Week High Date03/06/24
  • 52 Week Low2.00
  • 52 Week Low Date11/10/23
  • Market Cap713.411M
  • Shares Out148.63M
  • 10 Day Average Volume3.76M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change7.62

RATIOS/PROFITABILITY

  • EPS (TTM)-0.99
  • P/E (TTM)-4.83
  • Fwd P/E (NTM)-5.52
  • EBITDA (TTM)-79.40M
  • ROE (TTM)-127.64%
  • Revenue (TTM)58.442M
  • Gross Margin (TTM)90.96%
  • Net Margin (TTM)-138.15%
  • Debt To Equity (MRQ)82.22%

EVENTS

  • Earnings Date05/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ocular Therapeutix Inc

 

Profile

MORE
Ocular Therapeutix, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye. Its first commercial drug product, DEXTENZA, is for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis. It is also developing two other...
Pravin Dugel M.D.
Executive Chairman of the Board, President, Chief Executive Officer
Donald Notman Jr.
Chief Financial Officer
Peter Jarrett Ph.D.
Chief Technical Officer
Philip Strassburger Esq., J.D.
General Counsel
Address
15 Crosby Drive
Bedford, MA
01730
United States

Top Peers

SYMBOLLASTCHG%CHG
EYPT
EyePoint Pharmaceuticals Inc
17.63UNCHUNCH
SIGA
SIGA Technologies Inc
8.83UNCHUNCH
AQST
Aquestive Therapeutics Inc
3.73UNCHUNCH
ESPR
Esperion Therapeutics Inc
1.99UNCHUNCH
CDXC
Chromadex Corp
3.56UNCHUNCH